$CATB CATABASIS PHARMACEUTICALS INC Insider Trading Week 26/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CATABASIS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CATABASIS PHARMACEUTICALS INC in week 26/2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Jirousek Michael | Chief Scientific Of ... | Option Exercise | C | 0.00 | 5,261 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Jirousek Michael | Chief Scientific Of ... | Option Exercise | C | 0.00 | 856,571 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Jirousek Michael | Chief Scientific Of ... | Buy | C | 0.00 | 409 | 0 | 246,093 | 245.7 K to 246.1 K (+0.17 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Jirousek Michael | Chief Scientific Of ... | Buy | C | 0.00 | 66,658 | 0 | 245,684 | 179 K to 245.7 K (+37.23 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Option Exercise | A | 12.21 | 11,094 | 135,458 | 11,094 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Option Exercise | C | 0.00 | 1,006,712 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Option Exercise | C | 0.00 | 7,388,491 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Option Exercise | C | 0.00 | 3,910,392 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Option Exercise | C | 0.00 | 8,666,667 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Buy | P | 12.00 | 12,422 | 149,064 | 90,764 | 78.3 K to 90.8 K (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Buy | P | 12.00 | 91,166 | 1,093,992 | 666,145 | 575 K to 666.1 K (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Buy | P | 12.00 | 155,188 | 1,862,256 | 1,133,943 | 978.8 K to 1.1 M (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Buy | C | 0.00 | 78,342 | 0 | 78,342 | 0 to 78.3 K |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Buy | C | 0.00 | 574,979 | 0 | 574,979 | 0 to 575 K |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Buy | C | 0.00 | 304,309 | 0 | 978,755 | 674.4 K to 978.8 K (+45.12 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | George Jean | Director | Buy | C | 0.00 | 674,446 | 0 | 674,446 | 0 to 674.4 K |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | GALAKATOS NICHOLAS | Director | Option Exercise | A | 12.21 | 11,094 | 135,458 | 11,094 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | GALAKATOS NICHOLAS | Director | Option Exercise | C | 0.00 | 9,728,971 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | GALAKATOS NICHOLAS | Director | Option Exercise | C | 0.00 | 20,800,000 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | GALAKATOS NICHOLAS | Director | Buy | P | 12.00 | 376,695 | 4,520,340 | 2,752,488 | 2.4 M to 2.8 M (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | GALAKATOS NICHOLAS | Director | Buy | C | 0.00 | 757,117 | 0 | 2,375,793 | 1.6 M to 2.4 M (+46.77 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | GALAKATOS NICHOLAS | Director | Buy | C | 0.00 | 1,618,676 | 0 | 1,618,676 | 0 to 1.6 M |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Donovan Joanne M. | Chief Medical Offic ... | Option Exercise | C | 0.00 | 5,261 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Donovan Joanne M. | Chief Medical Offic ... | Buy | C | 0.00 | 409 | 0 | 409 | 0 to 409 |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 9,728,971 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 20,800,000 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | P | 12.00 | 376,695 | 4,520,340 | 2,752,488 | 2.4 M to 2.8 M (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 0.00 | 757,117 | 0 | 2,375,793 | 1.6 M to 2.4 M (+46.77 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | C | 0.00 | 1,618,676 | 0 | 1,618,676 | 0 to 1.6 M |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | BATE KENNETH | Director | Option Exercise | A | 12.21 | 11,094 | 135,458 | 11,094 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 207,558 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 9,821,385 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 448,414 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Option Exercise | C | 0.00 | 21,218,253 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Buy | P | 12.00 | 8,094 | 97,128 | 59,139 | 51 K to 59.1 K (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Buy | P | 12.00 | 382,996 | 4,595,952 | 2,798,528 | 2.4 M to 2.8 M (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 16,152 | 0 | 51,045 | 34.9 K to 51 K (+46.29 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 764,309 | 0 | 2,415,532 | 1.7 M to 2.4 M (+46.29 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 34,893 | 0 | 34,893 | 0 to 34.9 K |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | SVLSF V, LLC | 10% Owner | Buy | C | 0.00 | 1,651,223 | 0 | 1,651,223 | 0 to 1.7 M |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | ROSS MICHAEL JAY | Director | Option Exercise | A | 12.21 | 11,094 | 135,458 | 11,094 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Modi Rick | Chief Business Offi ... | Option Exercise | C | 0.00 | 52,614 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Modi Rick | Chief Business Offi ... | Buy | C | 0.00 | 4,094 | 0 | 4,094 | 0 to 4.1 K |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Milne Jill C. | President and CEO | Option Exercise | C | 0.00 | 105,229 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Milne Jill C. | President and CEO | Option Exercise | C | 0.00 | 856,548 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Milne Jill C. | President and CEO | Buy | C | 0.00 | 8,189 | 0 | 253,872 | 245.7 K to 253.9 K (+3.33 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Milne Jill C. | President and CEO | Buy | C | 0.00 | 66,657 | 0 | 245,683 | 179 K to 245.7 K (+37.23 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 4,241,780 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 13,866,666 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | MedImmune Ventures, Inc. | 10% Owner | Buy | P | 12.00 | 223,439 | 2,681,268 | 1,632,652 | 1.4 M to 1.6 M (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | MedImmune Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 330,098 | 0 | 1,409,213 | 1.1 M to 1.4 M (+30.59 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | MedImmune Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 1,079,115 | 0 | 1,079,115 | 0 to 1.1 M |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Laufer Ron | Director | Option Exercise | A | 12.21 | 11,094 | 135,458 | 11,094 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Laufer Ron | Director | Option Exercise | C | 0.00 | 4,241,780 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Laufer Ron | Director | Option Exercise | C | 0.00 | 13,866,666 | 0 | 0 | |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Laufer Ron | Director | Buy | P | 12.00 | 223,439 | 2,681,268 | 1,632,652 | 1.4 M to 1.6 M (+15.86 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Laufer Ron | Director | Buy | C | 0.00 | 330,098 | 0 | 1,409,213 | 1.1 M to 1.4 M (+30.59 %) |
| Jun 30 2015 | CATB | CATABASIS PHARMACE ... | Laufer Ron | Director | Buy | C | 0.00 | 1,079,115 | 0 | 1,079,115 | 0 to 1.1 M |